Skip to content
Announcement:

Join us for our next LinkedIn Live Event on Thursday 26th June 2025, where Dr Maria Georgiou PhD, will present on "In Vitro Retinal Models: A New Era in Drug Discovery & Gene Therapy"

Updates: Retina - Page 2

Current Protocols in Stem Cell Biology
22nd October, 2019

Newcells Biotech acquires IP for retinal organoids

Newcells Biotech  is pleased to announce the acquisition of intellectual property pertaining to the methodology for the differentiation of three-dimensional retinal org

Read update
A close up image of a child's eye
2nd September, 2019

Vision for the future of childhood retinal dystrophies

The retina is the means through which most people primarily perceive the world and for children particularly, visual defects can affect educational, social and emotional development.1 The importance of retinal…

Read update
Congenital hypertrophy of the retinal pigment epithelium
24th July, 2019

NB RPE model to improve drug retinal toxicity assessment

Retinal toxicity is an adverse side effect that can cause (usually irreversible) deterioration of a person’s vision, when taking certain medication. This has…

Read update
The difference between normal vision and the vision of someone affected by retinitis pigmentosa
13th June, 2019

iPSC derived retinal organoids: A promising tool for modelling retinitis pigmentosa

Retinitis pigmentosa (RP) is a group of degenerative disorders of the retina, caused by mutations in one of more than 60 genes, including the genes for making rhodopsin

Read update
Valeria
17th September, 2018

iPSC-derived retinal organoids

The start of the field of stem cell biology dates back to 1938, when Hans Spemann suggested that a differentiated nucleus can express pluripotency. This was followed by decades…

Read update
Very close up image of an eye
20th June, 2018

Review article – Cellular regeneration strategies for macular degeneration: past, present & future

Abstract Despite considerable effort and significant therapeutic advances, age-related macular degeneration (AMD) remains the commonest cause of blindness in the developed world. Progressive late-stage AMD with outer retinal degeneration currently…

Read update
Newcells Biotech to develop 3D retinal organoids using hiPSC derived skin cells
11th January, 2018

NB to develop 3D retinal organoids using hiPSC derived skin cells

Newcells Biotech in partnership with Newcastle University has been awarded further funding from the NC3R CRACK IT project to create 3D retinal organoids that more closely recapitulate the structure…

Read update

Get our latest updates straight to your inbox

Book a Call